U.S. FDA

Lupin’s Somerset facility clears U.S. FDA Pre-Approval Inspection for Edaravone Oral Suspension

Lupin announces completion of U.S. FDA Pre-Approval Inspection at its Somerset, New Jersey facility with zero 483 observations

Generic equivalent of Vibramycin for Injection, the drug is indicated to reduce the development of drug-resistant bacteria and…